Celadon Pharmaceuticals (UK) Ltd is a private limited company registered at 32-33 Cowcross Street, London EC1M 6DF. Incorporated on 2019-01-28, this 5-year-old company is run by 2 directors and 1 secretary.
Director Jonathan T., appointed on 20 December 2022. Director James S., appointed on 20 December 2022.
Changing the topic to secretaries, we can name: Kerin W., appointed on 20 December 2022.
The company is categorised as "manufacture of pharmaceutical preparations" (SIC: 21200). According to official data there was a change of name on 2022-03-25 and their previous name was Celadon Pharmaceuticals Ltd.
The last confirmation statement was filed on 2023-01-02 and the due date for the following filing is 2024-01-16. Furthermore, the annual accounts were filed on 31 December 2022 and the next filing is due on 30 September 2024.
Office Address | 32-33 Cowcross Street |
Town | London |
Post code | EC1M 6DF |
Country of origin | United Kingdom |
Registration Number | 11793377 |
Date of Incorporation | Mon, 28th Jan 2019 |
Industry | Manufacture of pharmaceutical preparations |
End of financial Year | 31st December |
Company age | 5 years old |
Account next due date | Mon, 30th Sep 2024 (132 days left) |
Account last made up date | Sat, 31st Dec 2022 |
Next confirmation statement due date | Tue, 16th Jan 2024 (2024-01-16) |
Last confirmation statement dated | Mon, 2nd Jan 2023 |
The register of persons with significant control that own or have control over the company consists of 2 names. As BizStats discovered, there is Vertigrow Technology Limited from London, England. The abovementioned PSC is categorised as "a limited" and has 75,01-100% shares. The abovementioned PSC and has 75,01-100% shares. Another entity in the persons with significant control register is Paul A. This PSC owns 75,01-100% shares and has 75,01-100% voting rights.
Vertigrow Technology Limited
32-33 Cowcross Street Cowcross Street, London, EC1M 6DT, England
Legal authority | Companies Act 2006 |
Legal form | Limited |
Notified on | 1 January 2020 |
Nature of control: |
75,01-100% shares |
Paul A.
Notified on | 28 January 2019 |
Ceased on | 1 January 2020 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Celadon Pharmaceuticals | March 25, 2022 |
Profit & Loss | ||||
---|---|---|---|---|
Accounts Information Date | 2020-01-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
Balance Sheet | ||||
Net Assets Liabilities | 1 | 1 | 1 | 1 |
Other | ||||
Called Up Share Capital Not Paid Not Expressed As Current Asset | 1 | 1 | 1 | 1 |
Number Shares Allotted | 1 | 1 | 1 | 1 |
Par Value Share | 1 | 1 | 1 | 1 |
Type | Category | Free download | |
---|---|---|---|
CS01 |
Confirmation statement with no updates 2024-01-02 filed on: 2nd, January 2024 |
confirmation statement | Free Download (3 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy